CHU UCL Namur site Godinne
Yvoir, Namur, 5530, Belgium
NCT Number: NCT06145204
The vascular physiotherapy department of the UCL University Clinics of Mont-Godinne specializes in the physiotherapeutic management of lymphoedema. Since 2018, an agreement has been established with INAMI to evaluate the effect of complex decongestion therapy on lymphoedema and its impact on patients' quality of life.
One of the aims of the treatment is to reduce the volume of lymphoedema and the discomfort or even pain associated with it. More generally, pain can have a significant functional impact, especially when it becomes chronic. As pain is subjective and influenced by many factors, it is difficult to assess it. Therefore it is interesting to consider psychosocial factors when assessing pain, in order to propose a global management approach.
At Mont-Godinne, pain-related data is currently collected on a numerical scale from 0 to 10, using the Lymph-ICF questionnaire. Moreover, in Belgium, reimbursement for lymphoedema care in the form of pathology E or F is based mainly on volume measurements.
The main aim of this study is to identify correlations between lymphoedema volume and pain related to lower limbs and to determine if pain could reduced when lymphoedema volume is decreased using current therapy. The second objective is collecting demographic data to assess the need for a comprehensive, specific and systematic approach to pain in the management of lymphoedema.
To proceed this assessment, we have sought the opinion of the Ethics Committee regarding the anonymous collection of new data from patients treated via a medical history and the introduction of two validated questionnaires (Brief Pain Inventory - short version and Orebro Musculoskeletal Pain Screening Questionnaire (OMSPQ) - short version) at D0 (start of complex decongestion therapy), D4 (end of complex decongestion therapy) and M3-8 (start of next complex decongestion therapy). No interventions or measures other than those used in clinical practice will be added.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Yvoir, Namur, 5530, Belgium
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
anamnesis, OMSPQ, Brief Pain Inventory-short form, lymph-ICF-LL
Time frame: at the beginning (Day 0) and the end (Day 4) of the cure
we will compare the results in % between the beginning and the end of the cure
Time frame: at the beginning (Day 0) and the end (Day 4) of the cure and at the beginning of the next cure (Month 3 to 8)
we will compare the results in % between the beginning and the end of the cure and the beginning of the next cure
Time frame: at the beginning (Day 0) and the end (Day 4) of the cure and at the beginning of the next cure (Month 3 to 8)
we will compare the results between the beginning and the end of the cure and the beginning of the next cure with two scores: intensity and interference score
University Hospital of Mont-Godinne
Other
Effect of Complex Decongestive Therapy and Correlation Between Volume and Pain in Lower Limb Lymphedema: a Prospective Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05507346
Cardiovascular Diseases, Chronic Venous Insufficiency
Oakland, California, United States
View Trial DetailsNCT06200948
Gynecologic Cancer, Hemic and Lymphatic Diseases
Ankara, Bilkent/Çankaya, Turkey (Türkiye)
View Trial DetailsNCT05119517
Hemic and Lymphatic Diseases, Lymphatic Diseases
Stratford, New Jersey, United States
View Trial DetailsNCT05485454
Hemic and Lymphatic Diseases, Lymphatic Diseases
Houston, Texas, United States
View Trial Details